efficacy of semaglutide and tirzepatide in reducing liver fat A 72-week trial compared the two leading GLP-1 medications adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Tirzepatide vs. Semaglutide for Patients
Description
Its great for people on GLP-1 medications due to its incredibly low sodium content (only 136mg), which helps reduce bloating, and its simple assembly makes it a meal-prep staple
Plan for the future

It is already dispensed in a prefilled pen where a pre-determined concentration of the active solution is filled

If, after about 3-4 months, you fall behind your expected weight loss (for example, less than half the predicted loss at this point), it may be time to discuss GLP-1 therapy with your medical team

, , GLP-1 ,

Cost is roughly comparable across formats